Integrating Bioanalysis with Toxicokinetics and Pharmacokinetics at Quotient Sciences
Case Study , Bioanalysis

Case Study: Copper and Ceruloplasmin-Derived Copper Analysis

27 March 2024

A case study on how Quotient Sciences worked with a biotech company to validate assays for total copper by ICP-MS and ceruloplasmin-derived copper by LC-ICP-MS2, also analyzing Wilson’s Disease patient samples using fully validated methods. 

This project involved a biotech company with the mission of identifying, developing and providing access to innovative treatments to patients with rare diseases, with a focus on Wilson’s Disease.

27 March 2024